Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
BIOSECURE Act
Client: COMPLETE GENOMICS, INC. · Firm: CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND ASSOCIATES, INC.)
BIOSECURE Act (HR 7085) and other issues related to gene sequencing equipment and clarifying inaccurate information about the company's ownership and business to ensure company is not misplaced in legislation (for example Complete Genomics is owned by MGI Tech not BGI, and does not operate a data services company, and has no access to customer genetic data).
BIOSECURE Act
Client: COMPLETE GENOMICS, INC. · Firm: CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND ASSOCIATES, INC.)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
COMPLETE GENOMICS, INC. via CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND ASSOCIATES, INC.)
2024 · fourth_quarter · 4T
BIOSECURE Act (HR 7085) and other issues related to gene sequencing equipment and clarifying inaccurate information about the company's ownership and business to ensure company is not misplaced in legislation (for example Complete Genomics is owned by MGI Tech not BGI, and does not operate a data services company, and has no access to customer genetic data).
BIOSECURE Act (HR 7085) and other issues related to gene sequencing equipment and clarifying inaccurate information about the company's ownership and business to ensure company is not misplaced in legislation (for example Complete Genomics is owned by MGI Tech not BGI, and does not operate a data services company, and has no access to customer genetic data).
Source: Senate LDA
BIOSECURE Act (HR 7085) and other issues related to gene sequencing equipment and clarifying inaccurate information about the company's ownership and business to ensure company is not misplaced in legislation (for example Complete Genomics is owned by MGI Tech not BGI, and does not operate a data services company, and has no access to customer genetic data).
BIOSECURE Act
Client: COMPLETE GENOMICS, INC. · Firm: CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND ASSOCIATES, INC.)
BIOSECURE Act (HR 7085) and other issues related to gene sequencing equipment and clarifying inaccurate information about the company's ownership and business to ensure company is not misplaced in legislation (for example Complete Genomics is owned by MGI Tech not BGI, and does not operate a data services company, and has no access to customer genetic data).
BIOSECURE Act
Client: COMPLETE GENOMICS, INC. · Firm: CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND ASSOCIATES, INC.)
BIOSECURE Act (HR 7085) and other issues related to gene sequencing equipment and clarifying inaccurate information about the company's ownership and business to ensure company is not misplaced in legislation (for example Complete Genomics is owned by MGI Tech not BGI, and does not operate a data services company, and has no access to customer genetic data).
BIOSECURE Act
Client: COMPLETE GENOMICS, INC. · Firm: CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND ASSOCIATES, INC.)
BIOSECURE Act (HR 7085) and other issues related to gene sequencing equipment and clarifying inaccurate information about the company's ownership and business to ensure company is not misplaced in legislation (for example Complete Genomics is owned by MGI Tech not BGI, and does not operate a data services company, and has no access to customer genetic data).
BIOSECURE Act
Client: COMPLETE GENOMICS, INC. · Firm: CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND ASSOCIATES, INC.)
BIOSECURE Act (HR 7085) and other issues related to gene sequencing equipment and clarifying inaccurate information about the company's ownership and business to ensure company is not misplaced in legislation (for example Complete Genomics is owned by MGI Tech not BGI, and does not operate a data services company, and has no access to customer genetic data).
BIOSECURE Act
Client: COMPLETE GENOMICS, INC. · Firm: CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND ASSOCIATES, INC.)
BIOSECURE Act (HR 7085) and other issues related to gene sequencing equipment and clarifying inaccurate information about the company's ownership and business to ensure company is not misplaced in legislation (for example Complete Genomics is owned by MGI Tech not BGI, and does not operate a data services company, and has no access to customer genetic data).
BIOSECURE Act
Client: COMPLETE GENOMICS, INC. · Firm: CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND ASSOCIATES, INC.)
BIOSECURE Act (HR 7085) and other issues related to gene sequencing equipment and clarifying inaccurate information about the company's ownership and business to ensure company is not misplaced in legislation (for example Complete Genomics is owned by MGI Tech not BGI, and does not operate a data services company, and has no access to customer genetic data).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMPLETE GENOMICS, INC. via CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND ASSOCIATES, INC.)
2024 · third_quarter · Q3
BIOSECURE Act (HR 7085) and other issues related to gene sequencing equipment and clarifying inaccurate information about the company's ownership and business to ensure company is not misplaced in legislation (for example Complete Genomics is owned by MGI Tech not BGI, and does not operate a data services company, and has no access to customer genetic data).
BIOSECURE Act (HR 7085) and other issues related to gene sequencing equipment and clarifying inaccurate information about the company's ownership and business to ensure company is not misplaced in legislation (for example Complete Genomics is owned by MGI Tech not BGI, and does not operate a data services company, and has no access to customer genetic data).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMPLETE GENOMICS, INC. via CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND ASSOCIATES, INC.)
2024 · second_quarter · Q2
BIOSECURE Act (HR 7085) and other issues related to gene sequencing equipment and clarifying inaccurate information about the company's ownership and business to ensure company is not misplaced in legislation (for example Complete Genomics is owned by MGI Tech not BGI, and does not operate a data services company, and has no access to customer genetic data).
BIOSECURE Act (HR 7085) and other issues related to gene sequencing equipment and clarifying inaccurate information about the company's ownership and business to ensure company is not misplaced in legislation (for example Complete Genomics is owned by MGI Tech not BGI, and does not operate a data services company, and has no access to customer genetic data).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMPLETE GENOMICS, INC. via CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND ASSOCIATES, INC.)
2024 · first_quarter · Q1
BIOSECURE Act (HR 7085) and other issues related to gene sequencing equipment and clarifying inaccurate information about the company's ownership and business to ensure company is not misplaced in legislation (for example Complete Genomics is owned by MGI Tech not BGI, and does not operate a data services company, and has no access to customer genetic data).
BIOSECURE Act (HR 7085) and other issues related to gene sequencing equipment and clarifying inaccurate information about the company's ownership and business to ensure company is not misplaced in legislation (for example Complete Genomics is owned by MGI Tech not BGI, and does not operate a data services company, and has no access to customer genetic data).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMPLETE GENOMICS, INC. via CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND ASSOCIATES, INC.)
2024 · first_quarter · RR
Issues related to gene sequencing equipment and clarifying inaccurate information about the company's ownership and business to ensure company is not misplaced in legislation (for example Complete Genomics is owned by MGI Tech not BGI, and does not operate a data services company, and has no access to customer genetic data).
AMERICANS AGAINST DOUBLE TAXATION via CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND ASSOCIATES, INC.)
2017 · fourth_quarter · 4T
Advocating for full preservation of the state and local tax (SALT) deduction in tax reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICANS AGAINST DOUBLE TAXATION via CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND ASSOCIATES, INC.)
2017 · third_quarter · Q3
Advocating for full preservation of the state and local tax (SALT) deduction in tax reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICANS AGAINST DOUBLE TAXATION via CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND ASSOCIATES, INC.)
2017 · third_quarter · RR
Advocating for full preservation of the state and local tax (SALT) deduction in tax reform
Bank Secrecy, US Patriot Act and regulations persuant to these acts and compliance issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to the Insurance Industry and more specifically Annuities.
Issues relating to the Insurance Industry and more specifically Annuities.
Issues relating to the Insurance Industry and more specifically Annuities.
Bank Secrecy, US Patriot Act, regulations persuant to these acts and compliance issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Bank Secrecy, US Patriot Act, regulations persuant to these acts and compliance issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENWORTH FINANCIAL via CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND ASSOCIATES, INC.)
2005 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to the Insurance Industry and more specifically Annuities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE